Most of us have between 400-800 potentially toxic, carcinogenic, endocrinedisrupting, gene-damaging chemicals and toxic heavy metals accumulated over a lifetime and stored within our cells. This has been known for many years. What wasn’t known is that these toxins stimulate the growth of very dangerous infections (fungal, bacterial, viral)

For each equivalent of stored toxins and heavy metals there is an equal amount of pathogenic infections in the body, so it is equally important to treat infections and detoxify the body at the same time.

For the first time in history, TOTAL BODY DETOX addresses both of these problems simultaneously. To receive a complete information pack that includes an interview with Dr. Sherrill Sellman on CD, call 1-800-481-9987 or 480-874-1419 (Arizona), or visit our website at www.ihsite.com and click on Total Body Detox link to see Glenn’s video and brochures.

We now have powerful evidence that the following conditions and diseases are linked to and benefited by daily magnesium intake:

Magnesium intake reduces chances of stroke and heart attack. It reduces arterial tension – preventing spasms within the blood vessels – and helps discourage clotting within the arteries.

Magnesium aids in relaxing the arteries and is integral to energy production.

It is important to be aware that: 
Without magnesium over 300 enzymes in our body are unable to function properly
Two-thirds or more of the population is magnesium deficient

Magnesium deficiency cannot be cured with magnesium capsules. The new delivery system involves applying a natural, ocean-derived magnesium chloride solution known as Transdermal Magnesium that is quickly absorbed through the skin. It is a safe and effective way to replenish magnesium levels in your body.

In Transdermal Magnesium Therapy, Mark Sircus, Ac., O.M.D., a nationally certified acupuncturist, honorary doctor of Oriental Medicine, and founding director of the International Medical Veritas Association (IMVA), introduces you to the most important overlooked mineral on this planet. Read More

by Glenn Parhnam

In separate in vitro tests against two strains of the H5N1 avian bird flu subtype, both instances of the virus were successfully neutralized by International Health’s SilverSol Technology™ product, called Super Silver solution. The most recent findings are consistent with prior test using company products against the H3N2 and H1N1 flu subtypes.

SCOTTSDALE — October 9, 2008 — International Health, Scottsdale, Arizona distributor of a line of powerful products that utilize patented SilverSol Technology™ to combat many of the world’s most harmful pathogens, today announced successful preliminary results on tests performed using the Super Silver Solution against three strains of the Avian Bird Flu Virus.

Preliminary in vitro tests performed by two separate independent laboratories, usingInternational Health’s Super Silver Solution at 10 ppm (parts per million) against two strains of the H5-N1 and H3-N2 subtype of the Avian Bird Flu virus, indicated that theSuper Silver products could neutralize the virus.

“While we understand that these are preliminary studies, we are extremely encouraged by the results of this initial testing,” said Glenn Parnham, Director of Research & Development at International Health. “Our intent with these studies is to test the ability of the Super Silver Solution to disarm or kill the Avian Flu virus in a laboratory setting. It is a necessary and valuable next step in our continued efforts to gain an understanding of what this technology can do.”

The preliminary results of the tests using Super Silver products against the H5N1 Avian Bird Flu virus are consistent with a variety of pervious tests conducted using Super Silver products against the H3N2 and H1N1 flu subtypes. In all cases, Super Silver™ was able to successfully neutralize the virus.

International Health is engaged in continuing testing and study programs with variety of groups and labs in the United States and other nations examining the potential applications of the Super Silver Technology™.

For more information, contact Glenn Parnham, Director of Research & Development at International Health, at his research office in Arizona at 480-429-0021.